Haemonetics Corporation - HAE - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Haemonetics Corporation - SIC # 3841

Ticker	Exchange	SIC #	Website	Latest Ticker
HAE	New York	3841	http://www.haemonetics.com	41.30 -0.51
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Haemonetics Corporation Interesting HAE Put For July - May 20th, 2013 12:08 pm HAEMONETICS CORP Files SEC form 10-K, Annual Report - May 20th, 2013 8:33 am Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd., Interviews with The Wall Street Transcript: A Health Sciences Fund with a Long-Term Focus - May 17th, 2013 8:46 am Haemonetics Corporation - Analyst/Investor Day - May 16th, 2013 5:00 pm HAE Crosses Above Key Moving Average Level - May 16th, 2013 2:10 pm Bargain Hunters Take Note: Insider Cluster-Buying At HAE - May 8th, 2013 12:22 pm Insiders Buy the Holdings of XSLV - May 6th, 2013 8:09 am HAE Beats on Earnings, Revs in Line - May 3rd, 2013 12:55 pm HAEMONETICS CORP Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements and Exhibi - May 3rd, 2013 2:46 am Haemonetics Closes Hemerus Acquisition - May 2nd, 2013 11:20 am Haemonetics upgraded to Buy from Hold at Craig-Hallum - May 2nd, 2013 7:21 am Haemonetics Corp. Becomes Oversold (HAE) - May 1st, 2013 2:23 pm Haemonetics Completes Hemerus Medical Acquisition - May 1st, 2013 11:02 am Haemonetics Management Discusses Q4 2013 Results - Earnings Call Transcript - May 1st, 2013 10:10 am Haemonetics Earnings: Everything You Must Know Now - May 1st, 2013 7:31 am Haemonetics Corporation Earnings Call scheduled for 8:00 am ET today - May 1st, 2013 6:00 am Q4 2013 Haemonetics Corporation Earnings Release - Before Market Open - May 1st, 2013 5:07 am Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 201 - May 1st, 2013 5:00 am Haemonetics Completes Hemerus Medical, LLC Acquisition - May 1st, 2013 4:59 am HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit or Dis - Apr 30th, 2013 10:34 pm View All Current Headlines >>